Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch*
暂无分享,去创建一个
[1] T. Gudermann,et al. G protein-mediated stretch reception. , 2012, American journal of physiology. Heart and circulatory physiology.
[2] M. Chalfie. Neurosensory mechanotransduction , 2009, Nature Reviews Molecular Cell Biology.
[3] A. Johnson,et al. INTEGRATIVE ROLE OF THE LAMINA TERMINALIS IN THE REGULATION OF CARDIOVASCULAR AND BODY FLUID HOMEOSTASIS , 1996, Clinical and experimental pharmacology & physiology.
[4] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[5] B. Kobilka,et al. Identification of an Allosteric Binding Site for Zn2+on the β2 Adrenergic Receptor* , 2003, The Journal of Biological Chemistry.
[6] S. Golz,et al. OAT2 catalyses efflux of glutamate and uptake of orotic acid. , 2011, The Biochemical journal.
[7] Brian K. Kobilka,et al. Structural Instability of a Constitutively Active G Protein-coupled Receptor , 1997, The Journal of Biological Chemistry.
[8] B. Kobilka,et al. GPCR–Gα fusion proteins: molecular analysis of receptor–G-protein coupling , 1999 .
[9] John A. Frangos,et al. G protein-coupled receptors sense fluid shear stress in endothelial cells , 2006, Proceedings of the National Academy of Sciences.
[10] Pascale G. Charest,et al. Monitoring agonist‐promoted conformational changes of β‐arrestin in living cells by intramolecular BRET , 2005, EMBO reports.
[11] Sudarshan Rajagopal,et al. Quantifying Ligand Bias at Seven-Transmembrane Receptors , 2011, Molecular Pharmacology.
[12] T. Kenakin,et al. G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.
[13] K. Rakesh,et al. β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress , 2010, Science Signaling.
[14] Ryan T. Strachan,et al. Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin , 2011, Science Signaling.
[15] C. Kung,et al. A possible unifying principle for mechanosensation , 2005, Nature.
[16] Matthias Heidenreich,et al. Stretch‐activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries (1067.8) , 2014, Circulation research.
[17] Bernd Nilius,et al. Sensing pressure with ion channels , 2012, Trends in Neurosciences.
[18] B. Fredholm,et al. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells. , 1990, Molecular pharmacology.
[19] J. Krieger,et al. Shear stress-induced Ang II AT1 receptor activation: G-protein dependent and independent mechanisms. , 2013, Biochemical and biophysical research communications.
[20] E. Ashley,et al. APJ ACTS AS A DUAL RECEPTOR IN CARDIAC HYPERTROPHY , 2012, Nature.
[21] Ryan T. Strachan,et al. Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor (GPCR)* , 2014, The Journal of Biological Chemistry.
[22] Vadim Cherezov,et al. Allosteric sodium in class A GPCR signaling. , 2014, Trends in biochemical sciences.
[23] J. Wess,et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.
[24] M. Caron,et al. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] Kunhong Xiao,et al. Multiple ligand-specific conformations of the β2-adrenergic receptor. , 2011, Nature chemical biology.
[26] J. Violin,et al. β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .
[27] Willem Soudijn,et al. Allosteric modulation of G-protein-coupled receptors , 2001 .
[28] Lisa Nguyen,et al. Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance , 2010, Journal of Pharmacology and Experimental Therapeutics.
[29] Rob Leurs,et al. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. , 2007, Annual review of pharmacology and toxicology.
[30] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[31] T. Kenakin,et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor , 1995, Nature.
[32] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[33] Arun K Shukla,et al. Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors , 2008, Proceedings of the National Academy of Sciences.
[34] Where have all the active receptor states gone? , 2012, Nature chemical biology.
[35] I. Komuro,et al. Conformational switch of angiotensin II type 1 receptor underlying mechanical stress‐induced activation , 2008, EMBO reports.
[36] Xavier Deupi,et al. Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.
[37] R. Lefkowitz,et al. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. , 2012, Annual review of pharmacology and toxicology.
[38] D. Daniels,et al. Divergent behavioral roles of angiotensin receptor intracellular signaling cascades. , 2005, Endocrinology.
[39] J. Sadoshima,et al. Solving the Cardiac Hypertrophy Riddle: The Angiotensin II–Mechanical Stress Connection , 2013, Circulation research.
[40] V. Slepak,et al. Signal-Dependent Translocation of Transducin, RGS9-1-Gβ5L Complex, and Arrestin to Detergent-Resistant Membrane Rafts in Photoreceptors , 2002, Current Biology.
[41] Bryan L. Roth,et al. Molecular control of δ-opioid receptor signalling , 2014, Nature.
[42] P. Sexton,et al. Allosteric modulation of G protein-coupled receptors: A pharmacological perspective , 2011, Neuropharmacology.
[43] Patricia H Reggio,et al. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. , 2005, Life sciences.
[44] T. Gudermann,et al. AT1 receptors as mechanosensors. , 2011, Current opinion in pharmacology.
[45] J L Benovic,et al. Agonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity* , 1997, The Journal of Biological Chemistry.
[46] T. Gudermann,et al. Gq‐coupled receptors as mechanosensors mediating myogenic vasoconstriction , 2008, EMBO Journal.
[47] Keshava Rajagopal,et al. Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.
[48] M. Bouvier,et al. Differential β-Arrestin–Dependent Conformational Signaling and Cellular Responses Revealed by Angiotensin Analogs , 2012, Science Signaling.
[49] B. Kobilka. Structural insights into adrenergic receptor function and pharmacology. , 2011, Trends in pharmacological sciences.
[50] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[51] G. Osol,et al. Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. , 2002, American journal of physiology. Heart and circulatory physiology.
[52] R. Lefkowitz,et al. Recent developments in biased agonism. , 2014, Current opinion in cell biology.
[53] J. Violin,et al. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury. , 2012, American journal of physiology. Heart and circulatory physiology.
[54] S. Gammeltoft,et al. β‐Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high‐affinity conformations , 2010, British journal of pharmacology.
[55] S. Kudoh,et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II , 2004, Nature Cell Biology.